Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 2.3.2020 | EN | Official Journal of the European Union | C 68/51 |

---

Action brought on 27 December 2019 – Gustopharma Consumer Health v EUIPO – Helixor Heilmittel (HELIX ELIXIR)

(Case T-883/19)

(2020/C 68/60)

Language of the case: English

Parties

Applicant: Gustopharma Consumer Health, SL (Madrid, Spain) (represented by: A. Gómez López, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Helixor Heilmittel GmbH (Rosenfeld, Germany)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union trade mark HELIX ELIXIR – Application for registration No 15 035 991

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 23 October 2019 in Case R 100/2019-1

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | allow the present Appeal; |

|  |  |
| --- | --- |
| — | annul the contested decision; and/or |

|  |  |
| --- | --- |
| — | set aside the contested decision due to erroneous application of Article 8(1)(b) and enter a finding to the effect that there does not exist likelihood of confusion between the confronted trademarks; |

|  |  |
| --- | --- |
| — | issue a new Resolution granting EUTM Application No 15 035 991 HELIX ELIXIR for all the applied goods; and |

|  |  |
| --- | --- |
| — | order EUIPO (and Intervener, if he enters an appearance in proceedings) to pay the costs. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council |

---

[Top](#document1)